Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06214494
Other study ID # BFR-HITT
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date August 1, 2024

Study information

Verified date March 2024
Source MedStar National Rehabilitation Network
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Individuals surviving Chronic Ischemic Stroke have lingering walking deficits long after their infarct. The main goal of this study is to compare two high intensity treadmill walking programs to see which improves walking more. The main question we aim to answer is: How does blood flow restricted high-intensity treadmill training impact walking function? Participants will be randomly separated into two groups. One group will perform the high intensity treadmill training with blood flow restriction on their Stroke affected leg, while the second group performs high intensity treadmill training only. Every week participants will be asked to walk on the treadmill for a total of 75 minutes during 2x 1-hour sessions. On visit 1, participants will undergo strength, balance, and walking testing. They will then be treated 2x weekly for 4 weeks (visit 2-9) and be re-tested to track progress on visit 10. Participants will again be treated 2x weekly for 4 more weeks (visit 11-18) and be tested to see the end results on visit 19. Researchers will then compare both groups to see if blood flow restriction training changes walking function, strength, and balance.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 20
Est. completion date August 1, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults 18 years or older with history of single ischemic stroke >6months. - Ambulate without physical assistance over 10M with or without mobility aides and bracing in 180 seconds or less. Exclusion Criteria: - Concurrent physical or occupational therapy. - Vulnerable populations such as adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners will be excluded. - Resting BP >160/100mmHg even with medication. - People who have taken analgesics, dopamine, antipyretics, and any other drugs that can affect the function of the autonomic nervous system in the last 2 weeks and likely to be treated with such drugs during the course of the study. - Individuals who score 9 (greater than normal or minimal impairment) or more on the Short Blessed Cognitive Assessment (6 item) will be unable to give informed consent. - Any medical condition (including heart failure, unstable angina, aortic stenosis, arrhythmias, hypertrophic cardiomyopathy, depression of ST-segment, previous or active deep vein thrombosis (DVT) in the hemiparetic lower extremity, pulmonary embolism (PE), bypass surgery within last 3 months.) that, in the opinion of the investigator, might jeopardize the participants' safety.

Study Design


Intervention

Other:
Blood Flow Restricted High Intensity Treadmill Training
Blood Flow Restricted High Intensity Treadmill Training at 70% limb occlusion (on hemiparetic limb only) 2x weekly for 16 Sessions totaling minimum of 75 minutes weekly.
HITT
High Intensity Treadmill Training 2x weekly for 16 Sessions totaling minimum of 75minutes weekly.

Locations

Country Name City State
United States MedStar National Rehabilitation Hospital Washington District of Columbia

Sponsors (1)

Lead Sponsor Collaborator
MedStar National Rehabilitation Network

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Lower Extremity Limb Circumference Limb circumference (cm) of hemiparetic lower extremity and unaffected lower extremity will be taken to determine if limb hypertrophy has occurred. Baseline, Week 4 (up to one week), Week 8( up to one week)
Other 1 Repetition Maximum Strength Testing (Leg press) 1 Repetition Maximum Strength Testing (Leg press) is a measure of overall hemiparetic gross push strength and is measured as the greatest force (in lbs) a patient can push with hemiparetic lower extremity one time. Baseline, Week 4 (up to one week), Week 8( up to one week)
Other 1 Repetition Maximum Strength Testing (Knee Extension) 1 Repetition Maximum Strength Testing (Knee Extension) is a measure of isolated hemiparetic quadriceps strength and is measured as the greatest force (in lbs) a patient can extend their hemiparetic quadriceps one time. Baseline, Week 4 (up to one week), Week 8( up to one week)
Primary 6 Minute Walk Test The 6-minute walk test (6MWT) assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance. Baseline, Week 4 (up to one week), Week 8( up to one week)
Secondary 10 Meter Walk Test The 10MWT assesses walking speed in meters per second over a short duration. Baseline, Week 4 (up to one week), Week 8( up to one week)
Secondary 5 Time Sit to Stand The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements. Baseline, Week 4 (up to one week), Week 8( up to one week)
Secondary Functional Gait Assessment The FGA is used to assess postural stability during walking and assesses an individual's ability to perform multiple motor tasks while walking. The tool is a modification of the 8-item Dynamic Gait Index, developed to improve reliability and reduce ceiling effect. Each item is scored on an ordinal scale from 0 to 3, with 0 = severe impairment, 1 = moderate impairment, 2 = mild impairment, 3 = normal ambulation. The highest score = 30 indicating no impairment in postural stability during walking. Baseline, Week 4 (up to one week), Week 8( up to one week)
Secondary BERG Balance Scale The Berg Balance Scale (BBS) is a 14-item objective measure that assesses static balance and fall risk in adults. Item-level scores range from 0-4 and are determined by ability to perform the assessed activity Item scores are then summed with lower scores indicating higher fall risk. The maximum score = 56. Baseline, Week 4 (up to one week), Week 8( up to one week)
Secondary Activities Balance Confidence Scale-16 The ABC Scale is a self-report measure of balance confidence in performing various activities without losing balance or experiencing a sense of unsteadiness. Items are rated on a rating scale that ranges from 0 - 100. Score of zero represents no confidence, a score of 100 represents complete confidence.
Overall score is calculated by adding item scores and then dividing by the total number of items.
Baseline, Week 4 (up to one week), Week 8( up to one week)
See also
  Status Clinical Trial Phase
Recruiting NCT03993236 - Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke Phase 4
Completed NCT04069767 - Innovative Physiotherapy in Stroke Rehabilitation N/A
Recruiting NCT06342206 - The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Enrolling by invitation NCT04956211 - Periodontal Treatment and Ischemic Stroke N/A
Active, not recruiting NCT05098236 - Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage N/A
Completed NCT03942588 - High-intensity Interval Training After Stroke N/A
Recruiting NCT04949334 - Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke N/A
Terminated NCT04095767 - Assessing Safety and Performance of the ANA Catheter System, Combined With a Stent Retriever in Acute Ischemic Stroke N/A
Not yet recruiting NCT06352086 - Understanding Visual Processing After Occipital Stroke
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Completed NCT01937182 - The Efficacy of Citalopram Treatment in Acute Stroke Phase 2
Completed NCT03649295 - Combined Conventional Speech Therapy and Functional Electrical Stimulation in Dysphagia Following Stroke N/A
Recruiting NCT05303649 - Effects of Neuronavigated Theta Burst Stimulation in Therapy of Post-stroke Aphasia N/A
Completed NCT04233515 - Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County
Completed NCT05102877 - Sensory Versus Motor Level Neuromuscular Electrical Stimulation N/A
Completed NCT04089917 - A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients
Completed NCT05221112 - Effects of PNF Patterns Training on Trunk Balance, and Gait in Chronic Stroke Patients N/A
Not yet recruiting NCT05035953 - Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke Phase 2
Completed NCT06326801 - Resistive Diaphragmatic Breathing Exercise With Pursed Lips Breathing Exercise in Sub-acute Stroke Patients N/A